ARVINAS, INC. Investment Income, Interest
ARVINAS, INC. (ARVN) reported Investment Income, Interest of $5.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-04
- ARVINAS, INC. investment income, interest for the quarter ending 2026-06-30 was $5.50M, a 46.60% decline year-over-year.
- ARVINAS, INC. investment income, interest for the quarter ending 2026-03-31 was $6.40M, a 45.30% decline year-over-year.
- ARVINAS, INC. investment income, interest for the quarter ending 2025-12-31 was $7.40M, a 42.64% decline year-over-year.
- ARVINAS, INC. investment income, interest for the quarter ending 2025-09-30 was $9.00M, a 37.06% decline year-over-year.
- ARVINAS, INC. investment income, interest for fiscal 2025 was $38.40M, a 29.93% decline from fiscal 2024.
- ARVINAS, INC. investment income, interest for fiscal 2024 was $54.80M, a 41.24% increase from fiscal 2023.
- ARVINAS, INC. investment income, interest for fiscal 2023 was $38.80M, a 223.33% increase from fiscal 2022.
- ARVINAS, INC. investment income, interest for fiscal 2022 was $12.00M, a 566.67% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $5.50M 10-Q · filed 2026-08-04 | $11.90M 10-Q · filed 2026-08-04 | $19.30M derived: sum of 3 quarters · filed 2026-08-04 | $28.30M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $6.40M 10-Q · filed 2026-05-11 | $13.80M derived: sum of 2 quarters · filed 2026-05-11 | $22.80M derived: sum of 3 quarters · filed 2026-05-11 | $33.10M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $16.40M derived: sum of 2 quarters · filed 2026-02-24 | $26.70M derived: sum of 3 quarters · filed 2026-08-04 | $38.40M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $9.00M 10-Q · filed 2025-11-05 | $19.30M derived: sum of 2 quarters · filed 2026-08-04 | $31.00M 10-Q · filed 2025-11-05 | $43.90M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $10.30M 10-Q · filed 2026-08-04 | $22.00M 10-Q · filed 2026-08-04 | $34.90M derived: sum of 3 quarters · filed 2026-08-04 | $49.20M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $11.70M 10-Q · filed 2026-05-11 | $24.60M derived: sum of 2 quarters · filed 2026-05-11 | $38.90M derived: sum of 3 quarters · filed 2026-05-11 | $52.50M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $27.20M derived: sum of 2 quarters · filed 2026-02-24 | $40.80M derived: sum of 3 quarters · filed 2026-02-24 | $54.80M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $14.30M 10-Q · filed 2025-11-05 | $27.90M derived: sum of 2 quarters · filed 2025-11-05 | $41.90M 10-Q · filed 2025-11-05 | $54.10M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $13.60M 10-Q · filed 2025-08-06 | $27.60M 10-Q · filed 2025-08-06 | $39.80M derived: sum of 3 quarters · filed 2026-02-24 | $49.80M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $14.00M 10-Q · filed 2025-05-01 | $26.20M derived: sum of 2 quarters · filed 2026-02-24 | $36.20M derived: sum of 3 quarters · filed 2026-02-24 | $45.20M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $12.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $22.20M derived: sum of 2 quarters · filed 2026-02-24 | $31.20M derived: sum of 3 quarters · filed 2026-02-24 | $38.80M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $10.00M 10-Q · filed 2024-10-30 | $19.00M derived: sum of 2 quarters · filed 2024-10-30 | $26.60M 10-Q · filed 2024-10-30 | $32.30M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-06-30 | $9.00M 10-Q · filed 2024-07-30 | $16.60M 10-Q · filed 2024-07-30 | $22.30M derived: sum of 3 quarters · filed 2025-02-11 | $25.70M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-03-31 | $7.60M 10-Q · filed 2024-05-07 | $13.30M derived: sum of 2 quarters · filed 2025-02-11 | $16.70M derived: sum of 3 quarters · filed 2025-02-11 | $18.50M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2022-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $9.10M derived: sum of 2 quarters · filed 2025-02-11 | $10.90M derived: sum of 3 quarters · filed 2025-02-11 | $12.00M 10-K · filed 2025-02-11 | |
| 2022-09-30 | $3.40M 10-Q · filed 2023-11-07 | $5.20M derived: sum of 2 quarters · filed 2023-11-07 | $6.30M 10-Q · filed 2023-11-07 | $7.02M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $1.80M 10-Q · filed 2023-08-08 | $2.90M 10-Q · filed 2023-08-08 | $3.62M derived: sum of 3 quarters · filed 2024-02-27 | $3.99M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $1.20M 10-Q · filed 2023-05-05 | $1.82M derived: sum of 2 quarters · filed 2024-02-27 | $2.19M derived: sum of 3 quarters · filed 2024-02-27 | $2.55M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $620.91K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $989.46K derived: sum of 2 quarters · filed 2024-02-27 | $1.35M derived: sum of 3 quarters · filed 2024-02-27 | $1.80M 10-K · filed 2024-02-27 | $1.90M 10-K · filed 2022-02-28 |
| 2021-09-30 | $368.55K 10-Q · filed 2021-11-03 | $728.71K derived: sum of 2 quarters · filed 2021-11-03 | $1.18M 10-Q · filed 2021-11-03 | $1.61M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $360.16K 10-Q · filed 2021-08-05 | $810.54K 10-Q · filed 2021-08-05 | $1.25M derived: sum of 3 quarters · filed 2023-02-23 | $2.05M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $450.38K 10-Q · filed 2021-05-04 | $885.16K derived: sum of 2 quarters · filed 2023-02-23 | $1.69M derived: sum of 3 quarters · filed 2023-02-23 | $2.65M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $434.78K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.24M derived: sum of 2 quarters · filed 2023-02-23 | $2.20M derived: sum of 3 quarters · filed 2023-02-23 | $3.50M 10-K · filed 2023-02-23 | $3.59M 10-K · filed 2021-03-01 |
| 2020-09-30 | $800.24K 10-Q · filed 2021-11-03 | $1.77M derived: sum of 2 quarters · filed 2021-11-03 | $3.07M 10-Q · filed 2021-11-03 | $4.23M derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-06-30 | $965.85K 10-Q · filed 2021-08-05 | $2.26M 10-Q · filed 2021-08-05 | $3.43M derived: sum of 3 quarters · filed 2021-08-05 | $4.54M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $1.30M 10-Q · filed 2021-05-04 | $2.46M derived: sum of 2 quarters · filed 2021-05-04 | $3.57M derived: sum of 3 quarters · filed 2021-05-04 | $4.67M derived: sum of 4 quarters · filed 2021-05-04 | |
| 2019-12-31 | $1.16M 10-K · filed 2020-03-16 | $2.28M derived: sum of 2 quarters · filed 2020-11-05 | $3.37M derived: sum of 3 quarters · filed 2020-11-05 | $4.60M 10-K · filed 2022-02-28 | $4.56M 10-K · filed 2020-03-16 |
| 2019-09-30 | $1.11M 10-Q · filed 2020-11-05 | $2.20M derived: sum of 2 quarters · filed 2020-11-05 | $3.39M 10-Q · filed 2020-11-05 | $4.59M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $1.09M 10-Q · filed 2020-08-04 | $2.28M 10-Q · filed 2020-08-04 | $3.48M derived: sum of 3 quarters · filed 2020-08-04 | $4.00M derived: sum of 4 quarters · filed 2020-08-04 | |
| 2019-03-31 | $1.19M 10-Q · filed 2020-04-28 | $2.39M derived: sum of 2 quarters · filed 2020-04-28 | $2.91M derived: sum of 3 quarters · filed 2020-04-28 | $3.45M derived: sum of 4 quarters · filed 2020-04-28 | |
| 2018-12-31 | $1.20M 10-K · filed 2020-03-16 | $1.72M derived: sum of 2 quarters · filed 2020-03-16 | $2.26M derived: sum of 3 quarters · filed 2020-03-16 | $2.47M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $523.34K 10-K · filed 2020-03-16 | $1.06M derived: sum of 2 quarters · filed 2020-03-16 | $1.27M 10-Q · filed 2019-11-04 | $1.31M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $539.41K 10-K · filed 2020-03-16 | $750.65K 10-Q · filed 2019-08-05 | $786.43K derived: sum of 3 quarters · filed 2020-03-16 | $810.57K derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | $211.24K 10-K · filed 2020-03-16 | $247.02K derived: sum of 2 quarters · filed 2020-03-16 | $271.16K derived: sum of 3 quarters · filed 2020-03-16 | $329.06K derived: sum of 4 quarters · filed 2020-03-16 | |
| 2017-12-31 | $35.78K 10-K · filed 2019-03-26 | $59.92K derived: sum of 2 quarters · filed 2019-03-26 | $117.83K derived: sum of 3 quarters · filed 2019-03-26 | $201.39K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $24.14K 10-K · filed 2019-03-26 | $82.04K derived: sum of 2 quarters · filed 2019-03-26 | $165.61K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $57.90K 10-K · filed 2019-03-26 | $141.47K derived: sum of 2 quarters · filed 2019-03-26 | |||
| 2017-03-31 | $83.56K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |